Blog

OncoSec’s “What We’re Reading”: Volume 2

Each week at OncoSec, we come across a wide range of news material. This week, we continue our “What We’re Reading” series, with our second instalment. There have been quite a number of recent articles regarding cancer, the biotech industry and treatment methods but we would like to highlight three that you might find interesting and informative.

Continue reading “OncoSec’s “What We’re Reading”: Volume 2”